Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Neurobo Pharmaceuticals stock
Learn how to easily invest in Neurobo Pharmaceuticals stock.
Neurobo Pharmaceuticals Inc is a biotechnology business based in the US. Neurobo Pharmaceuticals shares (NRBO) are listed on the NASDAQ and all prices are listed in US Dollars. Neurobo Pharmaceuticals employs 5 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Neurobo Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NRBO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Neurobo Pharmaceuticals stock price (NASDAQ: NRBO)Use our graph to track the performance of NRBO stocks over time.
Neurobo Pharmaceuticals shares at a glance
|Latest market close||$13.26|
|52-week range||$7.41 - $74.40|
|50-day moving average||$13.29|
|200-day moving average||$21.70|
|Wall St. target price||$16.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.61|
Buy Neurobo Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Neurobo Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neurobo Pharmaceuticals price performance over time
|1 week (2022-09-28)||-0.60%|
|1 month (2022-09-02)||4,233.33%|
|3 months (2022-07-05)||2,782.61%|
|6 months (2022-04-05)||1,389.89%|
|1 year (2021-10-05)||502.73%|
|2 years (2020-10-05)||129.41%|
|3 years (2019-10-04)||3,688.57%|
|5 years (2017-10-05)||31.55%|
Neurobo Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-84.95%|
|Return on equity TTM||-155.28%|
|Market capitalisation||$11.6 million|
TTM: trailing 12 months
Neurobo Pharmaceuticals share dividends
We're not expecting Neurobo Pharmaceuticals to pay a dividend over the next 12 months.
Have Neurobo Pharmaceuticals's shares ever split?
Neurobo Pharmaceuticals's shares were split on a 1:30 basis on 13 September 2022. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Neurobo Pharmaceuticals shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Neurobo Pharmaceuticals shares which in turn could have impacted Neurobo Pharmaceuticals's share price.
Neurobo Pharmaceuticals share price volatility
Over the last 12 months, Neurobo Pharmaceuticals's shares have ranged in value from as little as $7.41 up to $74.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neurobo Pharmaceuticals's is -0.3814. This would suggest that Neurobo Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Neurobo Pharmaceuticals has bucked the trend.
Neurobo Pharmaceuticals overview
NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. It develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. .
Neurobo Pharmaceuticals in the news
NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies
NeuroBo Shares Surge On Licensing, Equity Investment Pact With Korean Pharma Firm
Frequently asked questionsWhat percentage of Neurobo Pharmaceuticals is owned by insiders or institutions?
Currently 29.866% of Neurobo Pharmaceuticals shares are held by insiders and 27.161% by institutions. How many people work for Neurobo Pharmaceuticals?
Latest data suggests 5 work at Neurobo Pharmaceuticals. When does the fiscal year end for Neurobo Pharmaceuticals?
Neurobo Pharmaceuticals's fiscal year ends in December. Where is Neurobo Pharmaceuticals based?
Neurobo Pharmaceuticals's address is: 200 Berkeley Street, Boston, MA, United States, 02116 What is Neurobo Pharmaceuticals's ISIN number?
Neurobo Pharmaceuticals's international securities identification number is: US64132R1077 What is Neurobo Pharmaceuticals's CUSIP number?
Neurobo Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 36870A108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert